IP Library Granted Patent US 10,808,235
Granted Patent B2
US 10,808,235 · App. 15/781,857 · Granted Oct 20, 2020

Beta-glucosidase and uses thereof

Inventor: Johannes Gustaaf Ernst Van Leeuwen (Echt, NL)
Assignee: DSM IP Assets B.V.
C12N9/2428C12N9/2437C12N9/2445C12P19/02C12P19/14C12N15/80C12Y302/01003
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,808,235
App. No.
15/781,857
Granted
Oct 20, 2020
Kind
B2
Abstract

The application relates to a polypeptide having beta-glucosidase activity, its method of production and its uses.

Claims (14)

1. A variant polypeptide comprising substitution G142S at a position corresponding to position 142 of the polypeptide of SEQ ID NO:2, wherein the variant polypeptide has beta-glucosidase activity and at least 90% sequence identity to the polypeptide of SEQ ID NO:2.

2. The variant polypeptide according to claim 1 , which further comprises at least one substitution at a position of the polypeptide of SEQ ID NO:2 selected from positions 90, 103, 335, 485, 606, and any combination thereof.

3. The variant polypeptide according to claim 1 , wherein the variant polypeptide is less sensitive to glucose inhibition than the polypeptide of SEQ ID NO:2.

4. A composition comprising:

(i) the variant polypeptide according to claim 1 , and

(ii) a cellulase and/or a hemicellulase and/or a pectinase.

5. The composition according to claim 4 , wherein the cellulase is selected from the group consisting of a lytic polysaccharide monooxygenase, a cellobiohydrolase I, a cellobiohydrolase II, an endo-beta-1,4-glucanase, a beta-glucosidase and a beta-(1,3)(1,4)-glucanase or any combination thereof and the hemicellulase is selected from the group consisting of an endoxylanase, a beta-xylosidase, an alpha-L-arabinofuranosidase, an alpha-D-glucuronidase, an acetyl-xylan esterase, a feruloyl esterase, a coumaroyl esterase, an alpha-galactosidase, a beta-galactosidase, a beta-mannanase, a beta-mannosidase or any combination thereof.

6. The composition according to claim 4 , wherein the composition is a whole fermentation broth.

7. A method for the treatment of a substrate comprising cellulose and/or hemicellulose which method comprises contacting the substrate with

(i) the variant polypeptide according to claim 1 or

(ii) a composition comprising the variant polypeptide according to claim 1 , and a cellulase and/or a hemicellulase and/or a pectinase.

8. A method of producing a fermentation product, which method comprises:

a) treating a substrate using the method according to claim 7 to produce a material, and

b) fermenting the resulting material to produce the fermentation product.

Assignments (2)
CONFIRMATORY ASSIGNMENT Recorded Jun 12, 2023
From: DSM IP ASSETS B.V.
To: VERSALIS S.P.A.
Reel/Frame 063957/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 21, 2018
From: VAN LEEUWEN, JOHANNES GUSTAAF ERNST
To: DSM IP ASSETS B.V.
Reel/Frame 046646/0009 →
Priority Claims (4)
EP 15198788 · Dec 10, 2015 · regional
EP 15198826 · Dec 10, 2015 · regional
EP 15198893 · Dec 10, 2015 · regional
EP 15198902 · Dec 10, 2015 · regional
Continuity (1)
Related Publication 20180362945A1 · Dec 20, 2018